- Home
- ARVN vs DC Comparison
ARVN vs DC Comparison
Compare ARVN & DC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ARVN | DC |
|---|---|---|
| Founded | 2015 | 2017 |
| Country | United States | United States |
| Employees | N/A | 41 |
| Industry | Biotechnology: Pharmaceutical Preparations | Precious Metals |
| Sector | Health Care | Basic Materials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 781.0M | 783.8M |
| IPO Year | 2018 | N/A |
Fundamental Metrics
Financial Performance| Metric | ARVN | DC |
|---|---|---|
| Price | $10.13 | $4.56 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 20 | 4 |
| Target Price | ★ $15.35 | $9.48 |
| AVG Volume (30 Days) | 670.7K | ★ 1.6M |
| Earning Date | 04-30-2026 | 03-25-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 58.84 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $262,600,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $5.90 | $2.40 |
| 52 Week High | $14.22 | $7.25 |
Technical Indicators
Market Signals| Indicator | ARVN | DC |
|---|---|---|
| Relative Strength Index (RSI) | 31.91 | 32.87 |
| Support Level | $9.02 | $4.38 |
| Resistance Level | $10.18 | $5.08 |
| Average True Range (ATR) | 0.67 | 0.30 |
| MACD | -0.22 | -0.11 |
| Stochastic Oscillator | 4.18 | 11.22 |
Price Performance
Historical ComparisonAbout ARVN Arvinas Inc.
Arvinas Inc is a United States-based biopharmaceutical company focused on improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development and commercialization of therapies that degrade disease-causing proteins.. The company's proprietary Proteolysis-Targeting Chimera (PROTAC), work by inducing the cell's own ubiquitin-proteasome system to target, degrade and remove disease-causing proteins. The group's product candidates are bavdegalutamide, ARV-471 and ARV-766.
About DC Dakota Gold Corp.
Dakota Gold Corp is a gold exploration and development company with a specific focus on revitalizing the Homestake District in Lead, South Dakota. Dakota Gold has high-caliber gold mineral properties covering over 48 thousand acres surrounding the historic Homestake Mine. Company project includes Richmond Hill Project.